TELA Bio FY2026 Revenue expected to be more than $86.697M vs $86.849M Est

Benzinga Newsdesk www.benzinga.com Positive 62.5%

Neg 0% Neu 0% Pos 62.5%

TELA Bio (NASDAQ:TELA) FY2026 Revenue expected to be more than $86.697M vs $86.849M Est

Comments

No comments yet. Be the first!